Bayer Schering Pharma AG, formerly Schering AG is a global research-based company engaged in the development, manufacture and marketing of pharmaceutical products. It is engaged in research on new drugs and therapies. It divides its activities into four main segments. Women’s Healthcare includes such areas as female contraception and menopause management. Diagnostic Imaging includes magnetic resonance imaging (MRI) and X-ray contrast media. Specialized Therapeutics includes multiple sclerosis therapies. Oncology includes the hematological oncology and solid tumors areas. The Company's products include Yasmin, Yasminelle, Betaferon, Betaseron, Kogenate, Adalat, Avalox, Cipro, Mirena, Levitra, Magnevist and Glucobay, among others. Bayer Schering Pharma AG operates in five geographic regions: the Europe Region, United States Region, Japan Region, Latin America/Canada Region and Asia/Pacific Region and is headquartered in Berlin, Germany.